Careers  |  Sign In  |  Register

Latest in Hematology-Oncology

Reuters Health • The Doctor's Channel Daily Newscast

Risk Factors for Fractures During ADT

NEW YORK (Reuters Health) – A Canadian study has identified several readily available clinical factors that help determine the risk of fractures in men with prostate cancer undergoing androgen deprivation therapy. “Androgen deprivation therapy increases the risk of both fragility and non-fragility...

Reuters Health • The Doctor's Channel Daily Newscast

Less Harsh, as Effective Treatment for Multiple Myeloma

NEW YORK (Reuters Health) – The intensity of bortezomib-based regimens used to treat multiple myeloma in elderly patents can be reduced in order to lessen toxicity, without jeopardizing effectiveness. That’s according the results of a clinical trial reported in The Lancet Oncology published online...

Reuters Health • The Doctor's Channel Daily Newscast

Rasburicase Superior in Reducing Uric Acid

NEW YORK (Reuters Health) – Among adult patients being treated for hematologic malignancies and who are at high risk for tumor lysis syndrome with hyperuricemia, intravenous rasburicase does a better job than oral allopurinol in controlling plasma uric acid levels, according to a new study. “This drug...